Upcoming Events

How can we engineer organoids to better model human tissues and disease? In this CeMMinar, Matthias Lutolf (IHB/EPFL), a leading expert in stem cell bioengineering and organoid technology, will present his work on advanced organoid platforms, including shape-guided organoids, organs-on-chips, and bioprinted organoids, and their potential for biomedical research, drug discovery, and precision medicine.

What determines whether T cells respond successfully to cancer immunotherapy? Alice Kamphorst explores how costimulation and interactions between T cells, B cells, and antigen-presenting cells shape anti-tumor immunity, with the goal of understanding the cellular mechanisms that drive effective responses to immune checkpoint blockade.